Efficient and targeted chemo-gene delivery with self-assembled fluoro-nanoparticles for liver fibrosis therapy and recurrence

Jean-Philippe, 2013, Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice, Hepatology, 58, 1461, 10.1002/hep.26429 Uribe, 2014, Current treatment guidelines for chronic hepatitis B and their applications, J. Clin. Gastroenterol., 48, 773, 10.1097/MCG.0000000000000130 J K, 2019, Tumor necrosis factor-inducible gene 6 reprograms hepatic stellate cells into stem-like cells, which ameliorates liver damage in mouse, Biomaterials, 219, 119375, 10.1016/j.biomaterials.2019.119375 V K, 2016, Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis, Biomaterials, 76, 144, 10.1016/j.biomaterials.2015.10.047 S Y, 2018, Red blood cell-like particles with the ability to avoid lung and spleen accumulation for the treatment of liver fibrosis, Biomaterials, 156, 45, 10.1016/j.biomaterials.2017.11.031 Schuppan, 2012, Anti-fibrotic therapy: lost in translation?, J. Hepatol., 56, S66, 10.1016/S0168-8278(12)60008-7 Popov, 2009, Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies, Hepatology, 50, 1294, 10.1002/hep.23123 Schuppan, 2015, Liver fibrosis: common mechanisms and antifibrotic therapies, Clin Res Hepatol Gastroenterol, 39, S51, 10.1016/j.clinre.2015.05.005 Bhat, 2017, Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: a meta-analysis, PLoS One, 12, 10.1371/journal.pone.0185192 Vcharlotte, 2005, Sampling variability of liver biopsy in nonalcoholic fatty liver disease, Gastroenterology, 128, 1898, 10.1053/j.gastro.2005.03.084 Marcellin, 2013, Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study, Lancet, 381, 468, 10.1016/S0140-6736(12)61425-1 Blachier, 2013, The burden of liver disease in Europe: a review of available epidemiological data, J. Hepatol., 58, 593, 10.1016/j.jhep.2012.12.005 Ma, 2017, Sorafenib: a potential therapeutic drug for hepatic fibrosis and its outcomes, Biomed. Pharmacother., 88, 459, 10.1016/j.biopha.2017.01.107 Wang, 2010, New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis, J. Hepatol., 53, 132, 10.1016/j.jhep.2010.02.027 Liu, 2015, Improving oral bioavailability of sorafenib by optimizing the "Spring" and "Parachute" based on molecular interaction mechanisms, Mol. Pharm., 13, 599, 10.1021/acs.molpharmaceut.5b00837 Ganten, 2017, Sorafenib in patients with hepatocellular carcinoma-results of the observational INSIGHT study, Clin. Canc. Res., 23, 5720, 10.1158/1078-0432.CCR-16-0919 Su, 2018, Sorafenib-loaded polymeric micelles as passive targeting therapeutic agents for hepatocellular carcinoma therapy, Nanomedicine-Uk, 13, 1009, 10.2217/nnm-2018-0046 Bala, 2016, The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis, J. Hepatol., 64, 1378, 10.1016/j.jhep.2016.01.035 Cai, 2012, Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155, J. Mol. Cell Biol., 4, 341, 10.1093/jmcb/mjs044 Pellicoro, 2014, Liver fibrosis and repair: immune regulation of wound healing in a solid organ, Nat. Rev. Immunol., 14, 181, 10.1038/nri3623 Uz, 2018, Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer, J. Contr. Release, 294, 237, 10.1016/j.jconrel.2018.12.031 Ruffell, 2015, Macrophages and therapeutic resistance in cancer, Canc. Cell, 27, 462, 10.1016/j.ccell.2015.02.015 Peng, 2017, Reprogramming tumor-associated macrophages to reverse EGFR(T790M) resistance by dual-targeting codelivery of gefitinib/vorinostat, Nano Lett., 17, 7684, 10.1021/acs.nanolett.7b03756 Zhang, 2017, Strategies for improving the payload of small molecular drugs in polymeric micelles, J. Contr. Release, 261, 352, 10.1016/j.jconrel.2017.01.047 Kedar, 2010, Advances in polymeric micelles for drug delivery and tumor targeting, Nanomedicine-Uk, 6, 714, 10.1016/j.nano.2010.05.005 Liu, 2006, Formulation of drugs in block copolymer micelles: drug loading and release, Curr. Pharmaceut. Des., 12, 4685, 10.2174/138161206779026263 Wang, 2014, A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios, Nat. Commun., 5, 3053, 10.1038/ncomms4053 Dong, 2010, Novel fluorinated polysilsesquioxane hollow spheres: synthesis and application in drug release, Chem. Commun., 46, 7498, 10.1039/c0cc01658f Wang, 2016, Self-assembled fluorodendrimers in the co-delivery of fluorinated drugs and therapeutic genes, Polym Chem-Uk, 7, 2319, 10.1039/C6PY00153J Chen, 2018, Reversibly stabilized polycation nanoparticles for combination treatment of early- and late-stage metastatic breast cancer, ACS Nano, 12, 6620, 10.1021/acsnano.8b01482 Chen, 2017, Combining fluorination and bioreducibility for improved siRNA polyplex delivery, ACS Appl. Mater. Interfaces, 9, 4457, 10.1021/acsami.6b14184 Weiskirchen, 2017, Isolation and culture of primary murine hepatic stellate cells, Methods Mol. Biol., 1627, 165, 10.1007/978-1-4939-7113-8_11 Chen, 2017, Combining fluorination and bioreducibility for improved siRNA polyplex delivery, ACS Appl. Mater. Interfaces, 9, 4457, 10.1021/acsami.6b14184 Nishimura, 2017, Self-assembled polypeptide nanogels with enzymatically transformable surface as an siRNA delivery platform, Biomacromolecules, 18, 3913, 10.1021/acs.biomac.7b00937 Dai, 2018, Toxic reactive oxygen species enhanced synergistic combination therapy by self-assembled metal-phenolic network nanoparticles, Adv. Mater., 30, 10.1002/adma.201704877 Zhou, 2019, Size switchable nanoclusters fueled by extracellular ATP for promoting deep penetration and MRI〨uided tumor photothermal therapy, Adv. Funct. Mater., 1904144, 10.1002/adfm.201904144 Zhou, 2020, ATP-charged nanoclusters enable intracellular protein delivery and activity modulation for cancer theranostics, iScience, 23, 100872, 10.1016/j.isci.2020.100872 Qiao, 2018, Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis, J. Contr. Release, 283, 113, 10.1016/j.jconrel.2018.05.032 Naito, 2018, Enhanced intracellular delivery of siRNA by controlling ATP-responsivity of phenylboronic acid-functionalized polyion complex micelles, Macromol. Biosci., 18, 10.1002/mabi.201700357 Dou, 2019, Anti-atherosclerotic effects of LXRα agonist through induced conversion of M1 macrophage to M2, Am. J. Tourism Res., 11, 3825 Hao, 2015, Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell via the JNK and Akt signaling pathways, J. Gastroenterol. Hepatol., 30, 370 Wang, 2018, Effect of autophagy-associated proteins on the arecoline-induced liver injury in mice, Exp Ther Med, 16, 3041 Wu, 2016, High levels of glucose promote the activation of hepatic stellate cells via the p38-mitogen-activated protein kinase signal pathway, Genet. Mol. Res., 15, 10.4238/gmr.15038419 Chen, 2020, Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells, Faseb. J. : official publication of the Federation of American Societies for Experimental Biology, 34, 5178, 10.1096/fj.201902307RRR Zhang, 2016, Inhibition of tumor growth and metastasis by photoimmunotherapy targeting tumor-associated macrophage in a sorafenib-resistant tumor model, Biomaterials, 84, 1, 10.1016/j.biomaterials.2016.01.027 Li, 2016, Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-beta1/Smad pathway-mediated inhibition of extracellular matrix and autophagy, Drug Des. Dev. Ther., 10, 619 K C, 2007, Gene modulation for treating liver fibrosis, Crit. Rev. Ther. Drug Carrier Syst., 24, 93, 10.1615/CritRevTherDrugCarrierSyst.v24.i2.10 Kurowska-Stolarska, 2017, The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis, J. Allergy Clin. Immunol., 139, 1946, 10.1016/j.jaci.2016.09.021 Huang, 2018, Liver X receptor inverse agonist SR9243 suppresses nonalcoholic steatohepatitis intrahepatic inflammation and fibrosis, BioMed Res. Int., 2018, 8071093, 10.1155/2018/8071093 Lv, 2010, Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-beta1 in activated rat hepatic stellate cells, J. Ethnopharmacol., 132, 384, 10.1016/j.jep.2010.05.026 Hao, 2016, Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways, Anti Canc. Drugs, 27, 192, 10.1097/CAD.0000000000000316